Merck & Co. Pauses Enrollment Of Oral Islatravir In PrEP Studies As Bad News Mounts

 
• By Jessica Merrill
  
Pause Button
Merck paused enrollment in more studies testing Islatravir • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas